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Abstract
To obtain more evidence for intracellular magnetic ßuid hyperthermia (MFH), endocytosis and hyperthermia eƒcacy
of silan and dextran magnetite was investigated. Di⁄erential endocytosis was observed in dependence of nanoparticle and
cell type. Clonogenic survival was 3-fold lower after MFH versus waterbath hyperthermia. The selective “remote
inactivation” of cancer cells by an AC magnetic Þeld has been demonstrated in vitro.
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1. Introduction
Generally, hyperthermia is accomplished by
heating biocompatible, coated superparamagnetic
particles with an externally applied AC magnetic
Þeld (magnetic ßuid hyperthermia, MFH [1]). In
1979, Gordon et al. [2] were the Þrst to claim that
some kind of intracellular hyperthermia should oc-
cur if dextran magnetite nanoparticles were taken
up by cancer cells. They gave ferroßuids intra-
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venously to Sprague—Dawley rats bearing mam-
mary carcinomas and detected cellular particle
uptake by electron microscopy and iron staining
of the cancerous tissue. They also showed that
AC magnetic-Þeld-induced heating occurred, how-
ever, in their in vivo experiments, it was not pos-
sible to di⁄erentiate the biological e⁄ects of
interstitial (i.e. extracellular) from “real” intracellu-
lar heating.
Further experiments were done by Chan et al. in
1993 [3,4], which compared the clonogenic survival
fractions of A549 human lung adenocarcinoma
cells after water bath hyperthermia with the e⁄ect
of MFH. In the latter case, the cells were heated in
presence of dextran magnetite (1—3 mg ferrite/ml)
but were not allowed to take up particles intracel-
lularly. Hence, the extracellular e⁄ect of particle
heating was compared with waterbath inactivation.
No signiÞcant di⁄erences between both heating
methods were detected. The fascinating question
whether intracellular hyperthermia is really pos-
sible and which biological e⁄ect it might have in
comparison to conventional extracellular heating
was still not answered.
In several more comprehensive in vitro studies
published by us [5—10], ChanÕs data were con-
Þrmed with dextran magnetite and several human
carcinoma cell lines in vitro. In a second set of
experiments, the cancer cells were allowed to take
up particles for up to 100 h (0.8 mg ferrite/ml
growth medium) until the cells were heated either in
a water bath or with an externally applied AC
magnetic Þeld (520 kHz, 7—13 kA/m). The amount
of particles/cell was determined by measurements
of the cellular iron content. Up to 1 pg iron repres-
enting up to 107 particles and an intracellular speci-
Þc power absorption (SAR) of about 44 mW/ml
was determined in each of the cancer cells. This was
expected to be large enough for cell inactivation. In
contrast to these calculations and the observed
large particle uptake, no additional biological e⁄ect
of MFH over the waterbath heating was found. The
electron microscopy images indicated that many
particles had lost their shell. This was probably due
to lysosomal enzymatic dextran digestion which
yields overall large particle aggregation. It also
decreases SAR leading to decreased cellular heating
and therefore higher than expected cell survival.
In conclusion, dextran coated magnetite nano-
particles were classiÞed as not suitable for an intra-
cellular MFH approach.
Recent studies of Bacri et al. [11] and Halbreich
et al. [12] revealed some biological e⁄ects of AC
magnetic Þeld (1 MHz, 8 kA/m) excited magnetite
nanoparticles stabilized with dithiotreitol or coated
with 4-hydroxytamoxifen and b-estradiol 3-
glycidyl ether upon macrophages, monocytic cells
and MCF7 human breast cancer cells. In absence of
free nanoparticles no macroscopic heating but
a slight cellular inactivation of the MCF7 cells
(expressing estradiol receptors) was observed using
common viability tests whereas almost all mono-
cytes remained vital. However, due to some experi-
mental uncertainties, e.g. that the number of bound
particles per cells was too small for heat induced
inactivation and a questionable validity of viability
testing used in this study to evaluate MFH eƒcacy,
the overall conclusion of these studies are still un-
clear.
Intracellular magnetite nanoparticle uptake
alone has been reported several times. Besides up-
take into macrophages [13] or Kup⁄er cells of the
liver [14], T-cells take up those particles by low-
density lipoprotein (LDL) receptor-mediated en-
docytosis [15].
The present study was conducted to obtain more
evidence for biological e⁄ects of intracellular MFH.
Since it was known that dextran magnetite is not
suitable for this approach, we used a silan-type
coated ferroßuid preparation. It has a high enough
SAR and a general biocompatibility which is com-
parable to dextran magnetite. In addition, silan
coatings resist the enzymatic attack in lysosomes.
2. Materials and methods
The ferroßuids used in this study were the
dextran magnetite dP6 (Schering AG, not com-
mercially available) and the aminosilan-coated
magnetite preparation dBU48 (INM, not com-
mercially available). The characteristics of each
ferroßuid are summarized in Table 1. Prior to bio-
logical testing, sterile Þltration was performed.
Established cell lines provided by the American
type culture collection (ATCC) were the normal
human cerebral cortical neuronal cell line HCN-2
(ATCC CRL-10742), the human mammary carci-
noma line BT20 (ATCC HTB-19) and the colonic
adenocarcinoma line WiDr (ATCC CCL 218). The
Þbroblast line 97P599/3 was established from
a normal patient punch biopsy and the line RuSi-
RS1 was derived from a 67-yr-old glioblastoma
multiformae patient. Primary lines were cytochemi-
cally and cytologically conÞrmed as human and of
designated cell type. All cell lines were maintained
in their appropriate medium (HCN-2: DMEM with
15% FBS; BT20: BME, 1mM pyruvate, 5 ml non-
essential amino acids, 5 ml 100]vitamins, 40 IE
insulin, 1 mg/ml glucose; WiDr: RPMI 1640 with
10% FBS, 1 mM pyruvate; 97P599/3: medium 199,
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Table 1
Ferroßuid characteristics dP6 dBU48
Average particle core diameter 3.3 nm 13.1 nm
Average hydrodynamic particle diameter 50—70 nm 17 nm
Type of nanoparticle coating Dextran Aminosilan
Suspension stability as sterilized ßuid Years Months
Biocompatibility High High
Formation of intracellular particle aggregates Yes No
Superparamagnetic Yes Yes
Susceptibility 117.2 emu/g 50—100 emu/g
Surface charge Negative Highly positive
SpeciÞc absorption rate (SAR) 120 mW/mg Fe 146 mW/mg Fe
15% FBS; RuSi-RS1: BME, 10% FBS, 1 mM
pyruvate, 5 ml non-essential amino acids) at 37¡C,
5% carbon dioxide and 100% humidity. All cell
lines underwent regular passages and were routine-
ly checked for mycoplasma contamination.
The cells were grown in either dP6 or dBU48
containing medium (0.6 mg ferrite/ml) and the in-
tracellular iron concentration determined after 0, 6,
24, 48, 72, 144, 168 and 192 h using the methods
and washing procedures described earlier [5].
To determine particle uptake and distribution
throughout the cytoplasm, into phagosomes or lyso-
somes, transmission electron microscopy of se-
lected cell preparations was done. The attachment
of both particle types on the cell surface was deter-
mined by scanning electron microscopy.
Hyperthermia was performed either in a precise-
ly controlled waterbath according to standard pro-
cedures or in a special designed AC magnetic Þeld
applicator described earlier [5]. Brießy, magnetic
ßuid hyperthermia was performed by inserting
a small vial containing the test cells (5]107—1]108
cell pellet) into a thermostatized bolus which in
turn was inserted in a water-cooled copper coil, the
AC magnetic Þeld applicator. Before any treatment,
the cells were washed ten times with phosphate-
bu⁄ered saline (PBS) to remove loosely attached
particles from the cell surface. The cells were either
waterbath heated or AC magnetic Þeld excited both
in ferroßuid free medium at 520 kHz and
13.2 kA/m. A ßuorooptic probe (Luxtron Mod.
3204, Luxtron Corp., Santa Ana, CA, USA) was
used to measure the temperature inside the cell
pellet. A steady-state temperature was maintained
in the pellet by variation of the Þeld strength during
hyperthermia for the times indicated. Finally,
clonogenic survival was calculated [16].
In principle, it is possible that individual cells
take up none, a few or large amounts of ferroßuid
particles during growth in ferroßuid medium in
comparison to the average uptake value deter-
mined by the iron bulk measurements of cell pellets.
Since determination of the iron content of each
individual cell is not possible, we used a static
magnetic Þeld gradient of 50 mT to estimate the
proportion of cells which had taken up a suƒcient
amount of particles. We assumed that the cells,
which can be attracted by such a magnetic Þeld,
contain a suƒcient amount of particles for cell
inactivation by MFH. 50 microlitres of a ten times
washed cell suspension grown in dBU48 contain-
ing medium (144 h) was put into a hemacytometer
chamber and a neodymium—iron—boron magnet
was positioned besides the droplet. The cells not
fully attracted to the magnet were assumed to con-
tain none or very few ferroßuid particles. Using the
known depth and area of the hemacytometer, the
cell concentration per ml volume was calculated, as
well as the fraction of “non-attractable” cells in
percent. Since only BT20 cells were tested for MFH
survival, these measurements were only done with
this cell line.
3. Results
Iron uptake of malignant and normal cells was
determined after growth in 0.6 mg/ml either dP6
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Fig. 1. dP6 (A) and dBU48 (B) iron uptake of normal human
Þbroblast cells designated as 97P599/3 in dependence on growth
time.
or dBU48 ferrite containing medium at 8 time
points up to 192 h. Fig. 1A shows the iron uptake of
97P599/3 human Þbroblasts grown in dP6 con-
taining medium in comparison to dBU48 ferro-
ßuid medium (Fig. 1B). dP6 particles are rapidly
taken up within 6 h reaching 200 pg of iron per
cell (pg/cell), which increases continuously to
500 pg/cell after 192 h. dBU48 particles are taken
up much more slowly, i.e. 200 pg/cell are reached at
144 h. Also, the peak iron content is lower at
400 pg/cell. Fig. 2A (incubation with dP6) and
Fig. 2B (incubation with dBU48) depict the results
of iron uptake after ferroßuid incubation of WiDr
human colonic adenocarcinoma cells. A much
lower uptake is observed in these malignant cells
for both ferroßuid preparations reaching a max-
imum at 50 pg/cell. The strong time-dependency
observed with normal Þbroblasts is not present
with WiDr.
Fig. 2. dP6 (A) and dBU48 (B) iron uptake of malignant
human colonic adenocarcinoma cells of strain WiDr in depend-
ence on growth time.
Fig. 3A shows the iron uptake of the malignant
glioma cell line RuSi-RS1 after growth in dP6
containing medium and Fig. 3B gives the results
after dBU48 incubation. In comparison to the
Þbroblasts, the uptake di⁄erence between both fer-
roßuid types is completely inverse, i.e. dP6 is slow-
ly and to a less extent (peak at 120 pg/cell) taken up
in comparison to a rapid and large uptake of
dBU48 (peak at 400 pg/cell). Time dependency
of dP6 uptake is more pronounced than with
dBU48. After 6 h, nearly maximum uptake is
obtained.
Fig. 4A and Fig. 4B depict the iron uptake of
normal cortical neuronal cells (HCN-2), which is
the normal counterpart to the highly malignant
RuSi-RS1 cells. The uptake is far lower (8-fold) in
comparison to the malignant cell line and the di⁄er-
ence between both ferroßuids is rather marginal
(both concentrations peak at about 50 pg/cell).
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Fig. 3. dP6 (A) and dBU48 (B) iron uptake of malignant
human glioma cells designated as RuSi-RS1 in dependence on
growth time.
These quantitative results are expressively con-
Þrmed by observations of the vital culture in ferro-
ßuid containing medium in comparison to normal
medium. Fig. 5A shows a phase-contrast light
microscopic picture (100x) of a normal culture of
HCN-2 in comparison to the malignant counter-
part RuSi-RS1 shown in Fig. 6A. Whereas dP6
incubation (144 h, 0.6 mg/ml) does not alter pig-
mentation or viability of both cell types (except
a slight disposition to detachment from the surface,
Fig. 5B and Fig. 6B), incubation with dBU48
yields for the same time period and ferrite concen-
tration a slight cell pigmentation with HCN-2
(Fig. 5C). This happens to an even larger extent
with the malignant line RuSi-RS1 (Fig. 6C). These
observations are consistent with the iron uptake
data, which also indicated a large uptake of
dBU48 into RuSi-RS1, but not into HCN-2 and
a rather low dP6 uptake with both cell types.
Fig. 4. dP6 (A) and dBU48 (B) iron uptake of the normal
human cerebral cortical neuronal cell line HCN-2 in dependence
on growth time.
Scanning electron microscopy (SEM) of the
HCN-2 cell surface indicates large di⁄erences of
particle attachment between dP6 and dBU48.
Fig. 7A shows the normal surface of HCN-2,
Fig. 7B depicts the surface of HCN-2 after 72 h
at 0.6 mg/ml growth in dP6 containing me-
dium. For the same time period and concentra-
tion in Fig. 7C the cell surface after dBU48
incubation is shown. In Fig. 7B dP6, particles
are scattered as single particles all over the cell
membrane and are few in number. In Fig. 7C,
the dBU48 particles are attached to the cell
surface in large Þelds and are greater in number.
In comparison to these results with normal cells,
Fig. 8A (normal culture), Fig. 8B and Fig. 8C
indicate particle attachment to RuSi-RS1 cells.
In agreement with the iron uptake data, many
more dBU48 particles (Fig. 8C) are attached in
comparison to dP6. The white arrows indicate
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Fig. 7. Scanning electron microscopic (SEM) picture of a normal HCN-2 cell (A) and after 72 h growth in ferroßuid containing medium
either with dP6 (B) or dBU48 (C). The white arrows indicate particle Þelds or single aggregates of the ferroßuid preparations.
particle Þelds or single aggregates of the ferroßuid
preparations.
Since particle cell surface attachment is not ne-
cessarily an indicator for particle uptake, transmis-
sion electron microscopy (TEM) was performed to
characterize particle uptake into the cell cytoplasm.
Fig. 9A shows dP6 particles with HCN-2 cells and
Fig. 9B an analogous preparation with dBU48
after a 72 h incubation at 0.6 mg/ml ferroßuid con-
centration. In Fig. 9A nearly all visible dP6 par-
ticles are outside the cell (black arrows) and have
formed large aggregates, which may have been for-
med during the preparation procedures for electron
microscopy and thus are not necessarily present in
the living culture. In Fig. 9B it is diƒcult to decide
whether some particles have entered the cytoplasm,
but again most of the particles are outside the cell.
The circular shaped body besides the long healthy
HCN-2 cell is most probably detached debris of
a non-viable cell. Fig. 10A and Fig. 10B give an
impression of the huge particle uptake into the
RuSi-RS1 primary glioma cells after 72h dP6
(0.6 mg/ml) incubation (Fig. 10A) or within dBU48
containing medium of the same concentration
(Fig. 10B). The white arrows indicate extended
phagosomes containing a large number of particles
of both ferroßuid types. The dP6 particles appear
often to occur in aggregates, probably with lost or
partially degraded dextran shells, whereas almost
all dBU48 particles remain clearly separated.
In order to test the biological e⁄ect of these
intracellular particles, magnetic ßuid hyperthermia
was performed with dBU48 pre-incubated cells
(144 h, 0.6 mg/ml) after ten washes to completely
remove loosely attached and free particles in the
medium. For these experiments we used the estab-
lished mammary carcinoma cell line BT20 since
they had the capability to form distinct and repro-
ducible colonies as required for the clinically rel-
evant clonogenic assay.
191
Fig. 8. Scanning electron microscopic (SEM) picture of untreated RuSi-RS1 cells (A) and after 72 h growth in ferroßuid containing
medium either with dP6 (B) or dBU48 (C).
BT20 exhibits a quite similar dBU48 uptake
(data not shown) as RuSi-RS1, but does form
colonies with a plating eƒciency of more than 0.8.
Fig. 11A shows adherent BT20 cells with many
phagosomes containing large amounts of dBU48
particles. Fig. 11B indicates a BT20 cell which has
been enzymatically detached from the surface of the
culture ßask (trypsinization) prior to MFH treat-
ment, i.e. centrifugation and cell pellet formation.
A huge amount of ferroßuid particle containing
phagosomes or lysosomes can be seen in the circu-
lar-shaped cell.
Fig. 12A shows the survival curves after intracel-
lular MFH versus waterbath hyperthermia of par-
ticle containing BT20 cells (pre-incubation 144 h at
0.6 mg/ml) treated in ferroßuid-free medium at
a steady state temperature inside the cell pellet of
43¡C. Waterbath hyperthermia yields a typical
dose response curve in dependence on heating time,
which can be normally described with the multi-
target, single-hit model [16]. In contrast, the MFH
curve shows a 3-fold decrease (40 min) of the sur-
vival fraction in comparison to the very similar
waterbath hyperthermia. This survival di⁄erence is
pronounced at the clinically most important low
thermal doses, i.e. 10—60 min treatment time at
43¡C, but turns to nearly zero at 120 min. Fig. 12B
shows the results of a similar experiment at 45¡C.
The survival di⁄erences between magnetic ßuid and
waterbath hyperthermia are similar at maximum
(3-fold) but tend to zero much earlier at 25 min
treatment time in comparison to 43¡C at 120 min.
Fig. 11B is the TEM picture of a BT20 cell after
10 min MFH at 43¡C. In comparison to Fig. 11A
(no heating, growth in ferroßuid containing me-
dium only) a slight vacuolization process is discern-
able within the phagosomes or lysosomes
containing the dBU48 ferroßuid particles. This
can be seen in the micrograph by the appearance
of more or less white edges between the particle
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Fig. 9. Transmission electron microscopic (TEM) picture of HCN-2 cells 72 h growth in either dP6 (0.6 mg/ml) (A) or dBU48
(0.6 mg/ml) (B) containing medium.
Fig. 10. Transmission electron microscopic (TEM) picture of RuSi-RS1 primary glioma cells 72 h grown in either dP6 (0.6 mg/ml) (A)
or dBU48 (0.6 mg/ml) (B) containing medium.
accumulations and the endogenic phagosomal or
lysosomal membranes. This process turns to mass-
ive cell necrosis when the thermal dose is increased.
Fig. 11C shows a BT20 cell after 60 min, 43¡C
magnetic ßuid hyperthermia yielding a survival
fraction of only 10% (Fig. 12A).
Fig. 11D illustrates that parent cells, which have
taken up large amounts of dBU48 ferroßuid par-
ticles, cannot get rid of them. The two daughter
cells receive nearly 50% of the ferroßuid parent
mass, so that the “magnetic label” in dividing cells
will be diluted exponentially depending on popula-
tion doubling time.
If ferroßuid dBU48 144 h pre-incubated BT20
cells are trypsinized and the cell suspension is ex-
posed to a 50 mT static magnetic Þeld gradient
a cell portion of 11.2$2.1% does not move, i.e.
contains very few or no particles.
4. Discussion
Di⁄erential endocytosis of the dextran magnetite
dP6 and the silan coated magnetite dBU48 was
investigated with human malignant (WiDr, BT20,
RuSi) and normal (97P599/3, HCN-2) cells in vitro.
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Fig. 11. Transmission electron microscopic (TEM) picture of adherent human mammary carcinoma cells of strain BT20: (A) after 144 h
growth in dBU48 (0.6 mg/ml) containing medium; (B) BT20 cell in suspension grown under the same conditions; (C) after 60 min, 43¡C
magnetic ßuid hyperthermia yielding a survival fraction of only 10%. (D) During nucleus and cell division, particle containing
phagosomes are equal distributed to both daughter cells.
Normal Þbroblasts take up 200-fold dP6 iron
within the Þrst 6 h whereas dBU48 is taken up far
less within the Þrst 48 h. The malignant lines WiDr
and RuSi-RS1 have a completely di⁄erent uptake
behavior. RuSi-RS1 exibits a large and very fast
uptake of dBU48 in contrast to a low and slow
uptake of dP6. WiDr takes up only low amounts
of either dP6 or dBU48 with no time dependency,
which is quite similar to the glioma line HCN-2 (the
normal counterpart of RuSi-RS1). In conclusion, it
is obvious, that di⁄erent surface structures can be
used to induce di⁄erential endocytosis at least in
vitro. Since both particle surface structures do not
have ligands of biological speciÞcity, the process of
unspeciÞc endocytosis according to the “coated
pit” internalization process is the most probable
one. A huge number of particles are taken up so
quickly, they cannot be internalized by any speciÞc
receptors. In contrast to well known biologically
speciÞc internalization processes, little is known
about the extent and mechanisms of unspeciÞc en-
docytosis especially of cancer cells. Most of our
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Fig. 12. (A) Intracellular MFH versus homogeneous waterbath
heating at 43¡C (A). Within the Þrst 60 min MFH has a larger
eƒcacy due to additional e⁄ects of intracellular excited ferrof-
luid particles. At 120 min this e⁄ect tends to zero. At maximum,
the di⁄erence of the survival fractions between both heating
methods is nearly 3-fold. (B) After a 45¡C hyperthermia, this
e⁄ect is again 3-fold, but only within the Þrst 5 min. At 25 min
already the gain of intracellular MFH is zero in comparison to
waterbath hyperthermia.
knowledge is related to the phagocytosis of di⁄er-
ent polymer beads into macrophages, but less into
malignant cells. Much work has been done by
Kreuter et al. [17] upon the strategies to manipu-
late nanoparticle surfaces to enhance blood half
time and targeting to certain cells and tissues. How-
ever, most of the papers deal with chemical modiÞ-
cations, e.g. functionalized surfaces or surfactants
to circumvent the activity of the reticuloendothelial
system (RES), which normally captures all particles
of any size and structure out of the blood stream
into liver and spleen. From the present data, a large
di⁄erence of uptake between di⁄erent particles and
cell types has been demonstrated but interaction
with the RES has not been tested, so far.
REM and TEM analysis have indicated, that
di⁄erential endocytosis is obviously associated with
the adhesion capability of the particles to the cell
surface. In those cell lines, which had a minor
amount of particles on the outer membrane (Fig.
7B) in fact had a minor particle uptake (Fig. 3A). In
the case of RuSi-RS1 the opposite was true in terms
of dBU48 uptake: many particles on the cell sur-
face (Fig. 8C) are associated with large intracellular
uptake (Fig. 3B). Besides the chemical structure, the
only two known di⁄erent parameters between both
particle types are the hydrodynamic size and the
surface charge, which may be relevant to explain
this di⁄erential particle adhesion and internali-
zation capability (Table 1). Since dBU48 has
a nearly 4-fold lower particle size but a very high
surface charge due to linkage of many aminogroups
to the silan shell, electrostatic binding may be one
explanation of the observed adhesion. The counter-
part of the large positive particle surface charge
under physiological pH may be conjugate proteins
in the plasma membrane, which are supposed to
present more negatively charged amino acids onto
the surface of the cell.
Especially the TEM data indicate a further aspect
of di⁄erential endocytosis, which might be the divis-
ion activity or doubling time of the cell. Fast divid-
ing cells, like Þbroblasts and malignant cells exhibit
rather large uptake, whereas slower dividing cells
either malignant or normal like WiDr and HCN do
not take up much of both particle types. In the case
of malignant cells the relevance of this parameter is
supported by the known de-di⁄erentiation of high-
grade malignancies, which leads to a loss of speciÞc
cell functions and a decrease of membrane speciÞ-
city. Additionally, most of the actively growing tu-
mor cells have often bad physiological conditions in
their environment or micromilieu, due to hypoxia.
Especially when chaotic vascularization of a tumor
collapses after a therapeutic intervention, nutrient
supply is low. Then it might be an advantage for
tumor cells to use their unspeciÞc endocytosis ca-
pability to increase the probability of a random
nutrient ingestion, of which single components nor-
mally are recognized by speciÞc receptors (e.g. free
glucose) but are not available at the time.
How many particles each individual tumor cell
really takes up cannot be determined with the bulk
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experiments performed, so far. Therefore it might
be possible, that some cells at least in vitro take up
only a few or none of the particles whereas others
take up a large portion, which altogether yields the
uptake values shown in Figs. 1—4. From the magnet
experiments we know, that this low-uptake fraction
is with BT20 cells around 10%. Why some clono-
genic cells of a continuously dividing culture ex-
press such a di⁄erent endocytosis activity, is not
known so far. As is with radiation, drug and hyper-
thermia cell sensitivity, di⁄erent sub-populations or
a small portion of not actively dividing (G0) cells
may be one of the reasons for this di⁄erent behavior.
If tumor cells have taken up ferroßuid particles in
an amount of at least 200 pg/cell (Fig. 3B), inactiva-
tion is possible by an externally applied AC mag-
netic Þeld without particle deposit outside the cells.
This situation might occur in vivo by the activity of
the RES, which normally captures any particles out
of lymph capillaries and the blood stream. Hence,
only the ingested or paracellularly adhesive par-
ticles would contribute to heat-induced cell inac-
tivation. In addition to this fascinating “remote
killing” of cancer cells, Fig. 12A and Fig. 12B dem-
onstrate, that heat is not the only e⁄ect of intracel-
lular MFH. An additional e⁄ect is induced within
the Þrst 60 min, which further decreases the sur-
vival fraction in comparison to homogeneous
waterbath heating.
Random distribution of phagosomes might also
include heating of particles, which might be in the
neighborhood to heat sensitive organelles, like the
nucleus or plasma membrane or any of the signal
transduction molecules within the cell. According
to our electron microscopic Þndings, it is necrosis
not apoptosis, which kill the cells. No apoptotic
bodies or typical chromosome condensation was
observed. Instead, vacuolization and increase of the
cell body was obtained.
Intracellular MFH is no longer a matter of faith
and further studies will demonstrate its potential in
terms of cancer therapy or in any other medical
intervention not taken into account, so far.
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